DCLK1 is up-regulated and associated with metastasis and prognosis in colorectal cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DCLK1 is up-regulated and associated with metastasis and prognosis in colorectal cancer
Authors
Keywords
DCLK1, Colorectal cancer, Metastasis, Prognosis, Epithelial–mesenchymal transition
Journal
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume 142, Issue 10, Pages 2131-2140
Publisher
Springer Nature
Online
2016-08-12
DOI
10.1007/s00432-016-2218-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Colorectal cancer screening: a global overview of existing programmes
- (2015) Eline H Schreuders et al. GUT
- Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients
- (2015) Alireza Mirzaei et al. TUMOR BIOLOGY
- A new insight into cancer stem cell markers: Could local and circulating cancer stem cell markers correlate in colorectal cancer?
- (2015) Alireza Mirzaei et al. TUMOR BIOLOGY
- Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism
- (2015) Sripathi M. Sureban et al. Oncotarget
- EMT, CTCs and CSCs in tumor relapse and drug-resistance
- (2015) Abhisek Mitra et al. Oncotarget
- Doublecortin-Like Kinase 1 Is Elevated Serologically in Pancreatic Ductal Adenocarcinoma and Widely Expressed on Circulating Tumor Cells
- (2015) Dongfeng Qu et al. PLoS One
- XMD8-92 inhibits pancreatic tumor xenograft growth via a DCLK1-dependent mechanism
- (2014) Sripathi M. Sureban et al. CANCER LETTERS
- Methods for detecting circulating cancer stem cells (CCSCs) as a novel approach for diagnosis of colon cancer relapse/metastasis
- (2014) Carla Kantara et al. LABORATORY INVESTIGATION
- Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1
- (2014) Nathaniel Weygant et al. Molecular Cancer
- Epithelial-mesenchymal plasticity in carcinoma metastasis
- (2013) J. H. Tsai et al. GENES & DEVELOPMENT
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Dclk1 distinguishes between tumor and normal stem cells in the intestine
- (2012) Yuki Nakanishi et al. NATURE GENETICS
- Immunolocalization of DCAMKL-1, a putative intestinal stem cell marker, in normal colonic tissue
- (2012) Giuseppe Gagliardi et al. PATHOLOGY RESEARCH AND PRACTICE
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Transcription factors zeb1, twist and snai1 in breast carcinoma
- (2011) Ylermi Soini et al. BMC CANCER
- Identification of the putative intestinal stem cell marker doublecortin and CaM kinase-like-1 in Barrett's esophagus and esophageal adenocarcinoma
- (2011) Kenneth J Vega et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- EMT: New signals from the invasive front
- (2011) Xinhua Liang ORAL ONCOLOGY
- A Perspective on Cancer Cell Metastasis
- (2011) C. L. Chaffer et al. SCIENCE
- Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism
- (2011) Sripathi M Sureban et al. JOURNAL OF NANOBIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now